Literature DB >> 7962315

Therapeutic controversies: growth hormone (GH) treatment of non-GH deficient subjects.

D B Allen1, C G Brook, N A Bridges, P C Hindmarsh, H J Guyda, D Frazier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7962315     DOI： 10.1210/jcem.79.5.7962315

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  A rational approach to short stature: focus on use and abuse of growth hormone.

Authors:  J Krishna
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

2.  In children with idiopathic short stature, what advantage does administering recombinant growth hormone have over observation in final adult height?: Part B: Clinical commentary.

Authors:  Seth D Marks
Journal:  Paediatr Child Health       Date:  2003-11       Impact factor: 2.253

3.  Isolated haploinsufficiency of exon 1 of the SHOX gene in a patient with idiopathic short stature.

Authors:  Y-M Tan; K-Y Loke
Journal:  J Clin Pathol       Date:  2006-07       Impact factor: 3.411

Review 4.  Growth hormone treatment in non-growth hormone-deficient short children.

Authors:  S Loche; M R Casini; G M Ubertini; M Cappa
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

5.  Moral assessment of growth hormone therapy for children with idiopathic short stature.

Authors:  M Verweij; F Kortmann
Journal:  J Med Ethics       Date:  1997-10       Impact factor: 2.903
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.